Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals

  • Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU.

  • From the pharmacy to the bedside, we help you maximize safety, streamline processes and build cost efficiency throughout the hospital.

  • Acute and chronic nutritional care for your patients who are unable to get adequate nutrients orally or enterally.

  • Renal Care

    Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients.

  • Delivering innovative surgical products that help you operate with confidence, precision and speed.

  • Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

  • Baxter Education Center

    The Baxter Education Center (BEC) is a training center created for doctors, nurses, pharmacists and patients to improve knowledge and skills in therapeutic areas such as anesthesiology, acute kidney injury and chronic kidney disease, fluid therapy, and parenteral nutrition.

Perspectives

For more than 85-years, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do.

  • Inclusion & Diversity

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For more than 85 years, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients

  • When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one.

  • From the pharmacy to the bedside, we support you and your healthcare providers with IV medications and infusion technologies designed with safety in mind.

  • When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain or maintain your health.

  • Chronic kidney disease (CKD) is an ongoing journey. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs.

  • We partner with surgical teams around the world so they can operate with confidence, precision and speed for a successful outcome to your surgery.

  • Baxter Education Center

    The Baxter Education Center (BEC) is a training center created for doctors, nurses, pharmacists and patients to improve knowledge and skills in therapeutic areas such as anesthesiology, acute kidney injury and chronic kidney disease, fluid therapy, and parenteral nutrition.

Baxter Raises Quarterly Dividend

Press Release

PDF

Deerfield, Ill. -

Baxter International Inc. (NYSE:BAX) announced today that its Board of Directors has declared a 23 percent increase in the company’s quarterly dividend rate, from the previous rate of $0.13 per Baxter common share to $0.16 per share. The dividend is payable on July 3, 2017 to stockholders of record as of June 2, 2017.

“Baxter is pleased to raise our quarterly dividend rate, which reflects the company’s strong financial performance and commitment to enhancing shareholder value,” said José (Joe) E. Almeida, chairman and chief executive officer.  “This new rate aligns with our disciplined approach to capital allocation, as we strategically balance reinvestment in the business to drive sustainable growth along with returning value to our shareholders.”

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

This release includes forward-looking statements concerning Baxter's dividend. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: continued strength in the company’s financial position, including cash flows; future decisions of the board of directors of the company to continue payments to shareholders in the form of a dividend on a quarterly or other basis relative to alternative uses of funds; and other risks identified in the company's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter’s website. Baxter does not undertake to update its forward-looking statements.